Garnero P - Search Results

1

Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial.

van Tuyl LH, Lems WF, Voskuyl AE, Kerstens PJ, Garnero P, Dijkmans BA, Boers M. van Tuyl LH, et al. Among authors: garnero p. Ann Rheum Dis. 2008 Nov;67(11):1574-7. doi: 10.1136/ard.2008.090712. Epub 2008 Jul 14. Ann Rheum Dis. 2008. PMID: 18625629 Clinical Trial.

2

Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis.

Landewé RB, Geusens P, van der Heijde DM, Boers M, van der Linden SJ, Garnero P. Landewé RB, et al. Among authors: garnero p. Ann Rheum Dis. 2006 Jan;65(1):40-4. doi: 10.1136/ard.2004.035196. Epub 2005 Aug 26. Ann Rheum Dis. 2006. PMID: 16126801 Free PMC article. Clinical Trial.

3

Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis.

Landewé R, Geusens P, Boers M, van der Heijde D, Lems W, te Koppele J, van der Linden S, Garnero P. Landewé R, et al. Among authors: garnero p. Arthritis Rheum. 2004 May;50(5):1390-9. doi: 10.1002/art.20222. Arthritis Rheum. 2004. PMID: 15146408 Free article. Clinical Trial.

4

The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction.

Geusens PP, Landewé RB, Garnero P, Chen D, Dunstan CR, Lems WF, Stinissen P, van der Heijde DM, van der Linden S, Boers M. Geusens PP, et al. Among authors: garnero p. Arthritis Rheum. 2006 Jun;54(6):1772-7. doi: 10.1002/art.21896. Arthritis Rheum. 2006. PMID: 16736519 Free article. Clinical Trial.

5

Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study.

Garnero P, Landewé R, Boers M, Verhoeven A, Van Der Linden S, Christgau S, Van Der Heijde D, Boonen A, Geusens P. Garnero P, et al. Arthritis Rheum. 2002 Nov;46(11):2847-56. doi: 10.1002/art.10616. Arthritis Rheum. 2002. PMID: 12428224 Free article. Clinical Trial.

6

Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study.

Meulenbelt I, Kloppenburg M, Kroon HM, Houwing-Duistermaat JJ, Garnero P, Hellio Le Graverand MP, Degroot J, Slagboom PE. Meulenbelt I, et al. Among authors: garnero p. Ann Rheum Dis. 2006 Mar;65(3):360-5. doi: 10.1136/ard.2005.040642. Epub 2005 Aug 3. Ann Rheum Dis. 2006. PMID: 16079167 Free PMC article.

7

Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.

Chopin F, Garnero P, le Henanff A, Debiais F, Daragon A, Roux C, Sany J, Wendling D, Zarnitsky C, Ravaud P, Thomas T. Chopin F, et al. Among authors: garnero p. Ann Rheum Dis. 2008 Mar;67(3):353-7. doi: 10.1136/ard.2007.076604. Epub 2007 Jul 20. Ann Rheum Dis. 2008. PMID: 17644538 Clinical Trial.

8

Urinary type II collagen C-terminal peptide is associated with synovitis and predicts structural bone loss in very early inflammatory arthritis.

Freeston JE, Garnero P, Wakefield RJ, Hensor EM, Conaghan PG, Emery P. Freeston JE, et al. Among authors: garnero p. Ann Rheum Dis. 2011 Feb;70(2):331-3. doi: 10.1136/ard.2010.129304. Epub 2010 Oct 26. Ann Rheum Dis. 2011. PMID: 20980286

9

Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials.

Maksymowych WP, Landewe R, Boers M, Garnero P, Geusens P, El-Gabalawy H, Heinegard D, Kraus VB, Lohmander S, Matyas J, Saxne T, van der Heijde D. Maksymowych WP, et al. Among authors: garnero p. J Rheumatol. 2007 Mar;34(3):634-40. J Rheumatol. 2007. PMID: 17343311

10

Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis: a systematic literature search on 5 candidate biomarkers.

Syversen SW, Landewe R, van der Heijde D, Bathon JM, Boers M, Bykerk VP, Fitzgerald O, Gladman DD, Garnero P, Geusens P, El-Gabalawy H, Inman RD, Kraus V, Kvien TK, Mease PJ, Ostergaard M, Ritchlin CJ, Tak PP, Taylor WJ, Maksymowych WP. Syversen SW, et al. Among authors: garnero p. J Rheumatol. 2009 Aug;36(8):1769-84. doi: 10.3899/jrheum.090262. J Rheumatol. 2009. PMID: 19671812 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

287 results

Search Page

Filters